Literature DB >> 7702408

Secondary acute myeloid leukaemia with 7q- complicating azathioprine treatment for rheumatoid arthritis.

C C Mok, Y L Kwong, C S Lau.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7702408      PMCID: PMC1005544          DOI: 10.1136/ard.54.2.155-b

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  11 in total

1.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

2.  Toxic exposures and haematological disorders.

Authors:  Y L Kwong; K F Wong; T K Chan
Journal:  Br J Haematol       Date:  1994-06       Impact factor: 6.998

3.  Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia.

Authors:  H M Golomb; G Alimena; J D Rowley; J W Vardiman; J R Testa; C Sovik
Journal:  Blood       Date:  1982-08       Impact factor: 22.113

4.  Relation among occupational exposure to potential mutagenic/carcinogenic agents, clinical findings, and bone marrow chromosomes in acute nonlymphocytic leukemia.

Authors:  F Mitelman; L Brandt; P G Nilsson
Journal:  Blood       Date:  1978-12       Impact factor: 22.113

5.  Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis.

Authors:  H A Isomäki; T Hakulinen; U Joutsenlahti
Journal:  J Chronic Dis       Date:  1978

6.  Death rate and causes of death in patients with rheumatoid arthritis.

Authors:  H A Isomäki; O Mutru; K Koota
Journal:  Scand J Rheumatol       Date:  1975       Impact factor: 3.641

7.  Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents.

Authors:  S Vasquez; A F Kavanaugh; N R Schneider; M C Wacholtz; P E Lipsky
Journal:  J Rheumatol       Date:  1992-10       Impact factor: 4.666

8.  Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD Registry. Rheumatoid Arthritis Azathioprine Registry Steering Committee.

Authors:  E L Matteson; A R Hickey; L Maguire; H H Tilson; M B Urowitz
Journal:  J Rheumatol       Date:  1991-06       Impact factor: 4.666

9.  Cytogenetic characteristics of therapy-related acute nonlymphocytic leukaemia, preleukaemia and acute myeloproliferative syndrome: correlation with clinical data for 61 consecutive cases.

Authors:  J Pedersen-Bjergaard; P Philip
Journal:  Br J Haematol       Date:  1987-06       Impact factor: 6.998

Review 10.  Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci.

Authors:  B Johansson; F Mertens; F Mitelman
Journal:  Genes Chromosomes Cancer       Date:  1993-12       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.